Clinical Trial Update: A Safety Study of PC945 (Opelconazole) Prophylaxis or Pre-emptive Therapy Against Pulmonary Aspergillosis in Lung Transplant Recipients (OPERA-S Study) [Phase 2]

View source ↗

Summary

Phase 2 safety trial evaluating Opelconazole (PC945) for prophylaxis or pre-emptive therapy against pulmonary aspergillosis in lung transplant recipients; the s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Aspergillosis

Drugs mentioned

• Opelconazole (PC945)

Snippet

Sponsor: Pulmocide Ltd | Conditions: Pulmonary Aspergillosis | Phase 2 | Status: COMPLETED